In last trading session, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) saw 1.13 million shares changing hands with its beta currently measuring 0.46. Company’s recent per share price level of $0.82 trading at -$0.13 or -13.74% at ring of the bell on the day assigns it a market valuation of $2.05M. That closing price of ZVSA’s stock is at a discount of -1143.9% from its 52-week high price of $10.20 and is indicating a discount of -3.66% from its 52-week low price of $0.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.77 million shares which gives us an average trading volume of 891.43K if we extend that period to 3-months.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information

Upright in the red during last session for losing -13.74%, in the last five days ZVSA remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $0.82 price level, adding 22.64% to its value on the day. ZyVersa Therapeutics Inc’s shares saw a change of -22.62% in year-to-date performance and have moved -13.12% in past 5-day. ZyVersa Therapeutics Inc (NASDAQ:ZVSA) showed a performance of -32.77% in past 30-days. Number of shares sold short was 44416.0 shares which calculate 0.69 days to cover the short interests.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders

Insiders are in possession of 0.25% of company’s total shares while institution are holding 3.23 percent of that, with stock having share float percentage of 3.24%. Investors also watch the number of corporate investors in a company very closely, which is 3.23% institutions for ZyVersa Therapeutics Inc that are currently holding shares of the company.

On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 4.95 shares of worth $4059.0 or 0.20% of the total outstanding shares. The later fund manager was in possession of 1.39 shares on Dec 31, 2024 , making its stake of worth around $1143.0 in the company or a holder of 0.06% of company’s stock.